Geode Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-279,456
| Closed | -$124K | – | 4885 |
|
|
2023
Q1 | $124K | Hold |
279,456
| – | – | ﹤0.01% | 4260 |
|
|
2022
Q4 | $61K | Sell |
279,456
-656
| -0.2% | -$196 | ﹤0.01% | 4541 |
|
|
2022
Q3 | $101K | Hold |
280,112
| – | – | ﹤0.01% | 4576 |
|
|
2022
Q2 | $182K | Buy |
280,112
+5,694
| +2% | +$3.78K | ﹤0.01% | 4332 |
|
|
2022
Q1 | $225K | Sell |
274,418
-4
| -0% | -$4 | ﹤0.01% | 4321 |
|
|
2021
Q4 | $312K | Buy |
274,422
+71,352
| +35% | +$145K | ﹤0.01% | 4281 |
|
|
2021
Q3 | $507K | Buy |
203,070
+58,448
| +40% | +$162K | ﹤0.01% | 4022 |
|
|
2021
Q2 | $429K | Sell |
144,622
-156,124
| -52% | -$544K | ﹤0.01% | 4014 |
|
|
2021
Q1 | $1.05M | Buy |
300,746
+35,736
| +13% | +$199K | ﹤0.01% | 3534 |
|
|
2020
Q4 | $1.26M | Buy |
265,010
+25,110
| +10% | +$130K | ﹤0.01% | 3293 |
|
|
2020
Q3 | $1.17M | Buy |
239,900
+875
| +0.4% | +$4.14K | ﹤0.01% | 3151 |
|
|
2020
Q2 | $776K | Buy |
239,025
+120,526
| +102% | +$1.14M | ﹤0.01% | 3230 |
|
|
2020
Q1 | $606K | Buy |
118,499
+9,784
| +9% | +$39.6K | ﹤0.01% | 3218 |
|
|
2019
Q4 | $495K | Hold |
108,715
| – | – | ﹤0.01% | 3506 |
|
|
2019
Q3 | $665K | Hold |
108,715
| – | – | ﹤0.01% | 3378 |
|
|
2019
Q2 | $662K | Buy |
108,715
+26,768
| +33% | +$181K | ﹤0.01% | 3367 |
|
|
2019
Q1 | $454K | Buy |
81,947
+3,629
| +5% | +$23.6K | ﹤0.01% | 3471 |
|
|
2018
Q4 | $443K | Buy |
78,318
+26,459
| +51% | +$195K | ﹤0.01% | 3421 |
|
|
2018
Q3 | $544K | Hold |
51,859
| – | – | ﹤0.01% | 3432 |
|
|
2018
Q2 | $575K | Buy |
51,859
+2,391
| +5% | +$21.5K | ﹤0.01% | 3387 |
|
|
2018
Q1 | $395K | Hold |
49,468
| – | – | ﹤0.01% | 3479 |
|
|
2017
Q4 | $405K | Hold |
49,468
| – | – | ﹤0.01% | 3442 |
|
|
2017
Q3 | $306K | Hold |
49,468
| – | – | ﹤0.01% | 3522 |
|
|
2017
Q2 | $299K | Hold |
49,468
| – | – | ﹤0.01% | 3542 |
|
|
2017
Q1 | $262K | Buy |
49,468
+3,294
| +7% | +$19.2K | ﹤0.01% | 3554 |
|
|
2016
Q4 | $313K | Hold |
46,174
| – | – | ﹤0.01% | 3437 |
|
|
2016
Q3 | $340K | Buy |
46,174
+25,195
| +120% | +$182K | ﹤0.01% | 3405 |
|
|
2016
Q2 | $171K | Buy |
20,979
+4,651
| +28% | +$36.2K | ﹤0.01% | 3643 |
|
|
2016
Q1 | $97 | Hold |
16,328
| – | – | ﹤0.01% | 3840 |
|
|
2015
Q4 | $87K | Hold |
16,328
| – | – | ﹤0.01% | 3914 |
|
|
2015
Q3 | $65K | Hold |
16,328
| – | – | ﹤0.01% | 3977 |
|
|
2015
Q2 | $80K | Hold |
16,328
| – | – | ﹤0.01% | 3811 |
|
|
2015
Q1 | $64K | Hold |
16,328
| – | – | ﹤0.01% | 3831 |
|
|
2014
Q4 | $63K | Buy |
+16,328
| New | +$67.6K | ﹤0.01% | 3852 |
|
Other funds holding CEMI
Geode Capital Management's CEMI Position: Q2 2023 in Review
Geode Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 279,456 shares — an estimated $124K sold.
Geode Capital Management first reported a position in CEMI in Q4 2014 and held it in 34 quarters. The position peaked at $1.26M in Q4 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Geode Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 279,456 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $124K.
- Geode Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2014 and held it in 34 quarters.
- Geode Capital Management's Chembio diagnostics, Inc. position peaked at $1.26M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.